Allspring Global Investments Trims Stake in Globus Medical

The institutional investor reduced its position in the medical device company by 6.2% in Q4 2025.

Apr. 3, 2026 at 7:05am

Got story updates? Submit your updates here. ›

A highly detailed, cinematic macro photograph of the internal components and mechanics of a medical device, representing the complex technology and manufacturing behind Globus Medical's products.An extreme close-up of the intricate inner workings of a Globus Medical surgical implant highlights the company's engineering expertise and manufacturing capabilities.Audubon Today

Allspring Global Investments Holdings LLC trimmed its stake in shares of Globus Medical, Inc. (NYSE:GMED) by 6.2% in the fourth quarter, according to the company's recent SEC filing. The institutional investor owned 447,174 shares of the medical device company's stock, valued at $39,038,000 at the end of the reporting period.

Why it matters

This transaction provides insight into the investment strategy and portfolio adjustments of a major institutional investor in the medical device industry. Tracking changes in large shareholder positions can offer clues about market sentiment and future performance expectations for companies like Globus Medical.

The details

Allspring Global Investments sold 29,357 shares of Globus Medical stock in Q4 2025, reducing its overall position in the company by 6.2%. The institutional investor now owns approximately 0.33% of Globus Medical's outstanding shares.

  • Allspring Global Investments filed the transaction details in its Q4 2025 13F report.

The players

Allspring Global Investments Holdings LLC

An institutional investment management firm that oversees over $600 billion in assets.

Globus Medical, Inc.

A leading medical device company specializing in musculoskeletal solutions for spine and orthopedic applications.

Got photos? Submit your photos here. ›

The takeaway

This transaction reflects Allspring Global Investments' portfolio adjustments, but does not necessarily indicate broader market sentiment or future performance expectations for Globus Medical. Investors should continue to monitor the company's financial results, product pipeline, and competitive positioning to assess its long-term growth potential.